Autres langues

24/09 Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
24/09 Shuttle Pharmaceuticals : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
11/09 Shuttle Pharmaceuticals Holdings, Inc. has Changed its Name to United Compute Inc
28/08 Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter
15/07 Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts
15/07 Kartoon Studios (NYSE: TOON) Enters Catalyst-Rich Growth Phase
14/07 Top Midday Gainers
14/07 Top Premarket Gainers
26/06 United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site
25/06 United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting
09/06 Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time
15/05 Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
14/05 Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs
07/05 Shuttle Pharmaceuticals Holdings, Inc. Appoints Ryan Trasolini as Co-Chief Executive Officer
07/05 Shuttle Pharmaceuticals Holdings, Inc. Announces Resignation of Oleh Nabyt as Independent Director, Effective May 3, 2026
07/05 E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner
06/05 Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) completed the acquisition of United Dogecoin Inc.
01/05 Shuttle Pharmaceuticals Holdings, Inc. entered into a definitive agreement to acquire United Dogecoin Inc.
01/05 United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation
30/04 Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner
30/04 Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $11 million in funding
31/03 Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
31/03 Shuttle Pharmaceuticals Holdings, Inc. Auditor Raises 'Going Concern' Doubt
30/03 RETRANSMISSION, Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
27/03 Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
Aucun résultat pour cette recherche